Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Oncology Biomarker market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oncology Biomarkermarket, defines the market attractiveness level of Oncology Biomarker market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oncology Biomarker industry, describes the types of Oncology Biomarker market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncology Biomarker market and the development prospects and opportunities of Oncology Biomarker industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncology Biomarker market in Chapter 13.
By Player:
Genomic Health, Inc
GlaxoSmithKline plc
Novartis AG
Pfizer, Inc
Merck & Co, Inc
Eli Lilly and Company FHoffmann-La Roche Ltd
Abbott Laboratories
Bristol-Myers Squibb
Qiagen NV
By Type:
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Stomach Cancer
Others
By End-User:
Diagnostics
Drug Discovery and Development
Prognostics
Risk Assessment
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oncology Biomarker Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oncology Biomarker Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oncology Biomarker Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oncology Biomarker Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oncology Biomarker Market Analysis and Outlook to 2022
-
7.1 Global Oncology Biomarker Consumption (2017-2022)
-
7.2 United States Oncology Biomarker Consumption (2017-2022)
-
7.3 Europe Oncology Biomarker Consumption (2017-2022)
-
7.4 China Oncology Biomarker Consumption (2017-2022)
-
7.5 Japan Oncology Biomarker Consumption (2017-2022)
-
7.6 India Oncology Biomarker Consumption (2017-2022)
-
7.7 South Korea Oncology Biomarker Consumption (2017-2022)
8 Region and Country-wise Oncology Biomarker Market Analysis and Outlook to 2028
-
8.1 Global Oncology Biomarker Consumption Forecast (2022-2028)
-
8.2 United States Oncology Biomarker Consumption Forecast (2022-2028)
-
8.3 Europe Oncology Biomarker Consumption Forecast (2022-2028)
-
8.4 China Oncology Biomarker Consumption Forecast (2022-2028)
-
8.5 Japan Oncology Biomarker Consumption Forecast (2022-2028)
-
8.6 India Oncology Biomarker Consumption Forecast (2022-2028)
-
8.7 South Korea Oncology Biomarker Consumption Forecast (2022-2028)
9 Global Oncology Biomarker Market Outlook by Types and Applications to 2022
-
9.1 Global Oncology Biomarker Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Stomach Cancer Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Oncology Biomarker Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diagnostics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drug Discovery and Development Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Prognostics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Risk Assessment Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Oncology Biomarker Market Outlook by Types and Applications to 2028
-
10.1 Global Oncology Biomarker Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Stomach Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oncology Biomarker Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drug Discovery and Development Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Prognostics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Risk Assessment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Oncology Biomarker Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oncology Biomarker Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oncology Biomarker Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oncology Biomarker Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oncology Biomarker Market Competitive Analysis
-
14.1 Genomic Health, Inc
-
14.1.1 Genomic Health, Inc Company Details
-
14.1.2 Genomic Health, Inc Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Genomic Health, Inc Oncology Biomarker Product and Service
-
14.2 GlaxoSmithKline plc
-
14.2.1 GlaxoSmithKline plc Company Details
-
14.2.2 GlaxoSmithKline plc Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline plc Oncology Biomarker Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG Oncology Biomarker Product and Service
-
14.4 Pfizer, Inc
-
14.4.1 Pfizer, Inc Company Details
-
14.4.2 Pfizer, Inc Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer, Inc Oncology Biomarker Product and Service
-
14.5 Merck & Co, Inc
-
14.5.1 Merck & Co, Inc Company Details
-
14.5.2 Merck & Co, Inc Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck & Co, Inc Oncology Biomarker Product and Service
-
14.6 Eli Lilly and Company FHoffmann-La Roche Ltd
-
14.6.1 Eli Lilly and Company FHoffmann-La Roche Ltd Company Details
-
14.6.2 Eli Lilly and Company FHoffmann-La Roche Ltd Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly and Company FHoffmann-La Roche Ltd Oncology Biomarker Product and Service
-
14.7 Abbott Laboratories
-
14.7.1 Abbott Laboratories Company Details
-
14.7.2 Abbott Laboratories Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Abbott Laboratories Oncology Biomarker Product and Service
-
14.8 Bristol-Myers Squibb
-
14.8.1 Bristol-Myers Squibb Company Details
-
14.8.2 Bristol-Myers Squibb Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bristol-Myers Squibb Oncology Biomarker Product and Service
-
14.9 Qiagen NV
-
14.9.1 Qiagen NV Company Details
-
14.9.2 Qiagen NV Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Qiagen NV Oncology Biomarker Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oncology Biomarker
-
Figure Oncology Biomarker Picture
-
Table Global Oncology Biomarker Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Biomarker Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Biomarker Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oncology Biomarker Consumption by Country (2017-2022)
-
Figure United States Oncology Biomarker Consumption and Growth Rate (2017-2022)
-
Table Europe Oncology Biomarker Consumption and Growth Rate (2017-2022)
-
Figure China Oncology Biomarker Consumption and Growth Rate (2017-2022)
-
Figure Japan Oncology Biomarker Consumption and Growth Rate (2017-2022)
-
Figure India Oncology Biomarker Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oncology Biomarker Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Biomarker Consumption Forecast by Country (2022-2028)
-
Figure United States Oncology Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oncology Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oncology Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oncology Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oncology Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oncology Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Stomach Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Discovery and Development Consumption and Growth Rate (2017-2022)
-
Figure Global Prognostics Consumption and Growth Rate (2017-2022)
-
Figure Global Risk Assessment Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stomach Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Discovery and Development Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prognostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Risk Assessment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oncology Biomarker Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oncology Biomarker Export by Region (Top 5 Countries) (2017-2028)
-
Table Genomic Health, Inc (Foundation Year, Company Profile and etc.)
-
Table Genomic Health, Inc Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genomic Health, Inc Oncology Biomarker Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Oncology Biomarker Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Oncology Biomarker Product and Service
-
Table Pfizer, Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc Oncology Biomarker Product and Service
-
Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Oncology Biomarker Product and Service
-
Table Eli Lilly and Company FHoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company FHoffmann-La Roche Ltd Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company FHoffmann-La Roche Ltd Oncology Biomarker Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Oncology Biomarker Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Oncology Biomarker Product and Service
-
Table Qiagen NV (Foundation Year, Company Profile and etc.)
-
Table Qiagen NV Oncology Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qiagen NV Oncology Biomarker Product and Service
-
